GSK will use promising results from two studies of its experimental chronic hepatitis B therapy to support planned regulatory ...

Topline data were announced from two phase 3 studies evaluating bepirovirsen for the treatment of chronic hepatitis B.

GSK announced in January that its novel chronic hepatitis B (CHB) successfully met primary goals in two pivotal phase 3 ...

Federal health officials upended the immunization schedule for American children this week. These are the diseases affected.

Hepatitis B is a virus that can damage the liver and lead to lifelong health problems. The hepatitis B vaccine prevents short ...

The overhaul is the latest in a host of sweeping changes made under the Trump administration by health secretary Robert F ...

Though specific data for bepirovirsen remain under wraps, GSK plans to file for approval in the first quarter of 2026.

GSK's antisense-based drug for chronic hepatitis B (CHB), bepirovirsen, has hit the mark in two phase 3 trials and will be filed for approval as a potential first-in-class treatment for the disease.

Kerala has reported its highest-ever number of Hepatitis A cases. As of December 30, 2025, the state recorded 31,536 ...

Jaundice and hepatitis cases persist at VIT Bhopal, raising safety concerns despite campus reopening and student protests.

Kerala records its highest-ever Hepatitis A with 31,536 confirmed and probable cases and 82 deaths as of December 30, 2025..

Kerala is facing a severe hepatitis A outbreak, with over 31,500 cases and 82 deaths reported by late December. The ...